4th Nov 2014 09:57
LONDON (Alliance News) - Frontier IP Group PLC on Tuesday said one of its portfolio companies, Ex Scientia Ltd, has signed a collaboration agreement with Sunovion Pharmaceuticals Inc.
Under the deal, polypharmacology drug discovery company Ex Scientia will work with Sunovion on medicines for psychiatric disorders.
The deal is worth a total of USD4.8 million, with Ex Scientia getting a USD1 million upfront payment.
Frontier IP shares were untraded on Tuesday having last traded at 32.5 pence.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2014 Alliance News Limited. All Rights Reserved.
Related Shares:
Frontier Ip